Read research from the August 2022 session of the ASCO Plenary Series, which features a study that evaluated how common it is for people with lung cancer to have inherited genetic mutations known to increase cancer risk. Read More >>
lung cancer
August 15, 2022 · Brielle Gregory Collins, ASCO staff
June 15, 2022 · Brielle Gregory Collins, ASCO staff
In this podcast, experts discuss what people with early-stage lung cancer should know about molecular testing, including what it is, how it may be used in guiding treatment decisions, and several recent studies about its role in treatment planning. Read More >>
June 9, 2022 · H. Jack West, MD
Dr. H. Jack West shares what people with lung cancer should know about biomarker testing, including why it is important in planning treatment and what to expect during the testing process. Read More >>
March 15, 2022 · Amanda Nerstad
Lung cancer survivor Amanda Nerstad shares what it was like receiving a stage 4 diagnosis at age 39, the role genomic testing played in prolonging her quality of life, and how she and her family cope with the diagnosis. Read More >>
March 14, 2022 · Brielle Gregory Collins, ASCO staff
Read research from the March 2022 session of the ASCO Plenary Series, which highlights an immunotherapy combination to treat advanced melanoma and adding immunotherapy to chemotherapy to treat advanced non-small cell lung cancer. Read More >>